P02.59. Complexity of disease and population heterogeneity require a rethinking of clinical trial design

Bibliographic Details
Main Authors: Amri H, Haramati A, Abu-Asab M
Format: Article
Language:English
Published: BMC 2012-06-01
Series:BMC Complementary and Alternative Medicine
id doaj-fd96583e587b4ac4a615fc92f6ab8ae3
record_format Article
spelling doaj-fd96583e587b4ac4a615fc92f6ab8ae32020-11-25T02:38:57ZengBMCBMC Complementary and Alternative Medicine1472-68822012-06-0112Suppl 1P11510.1186/1472-6882-12-S1-P115P02.59. Complexity of disease and population heterogeneity require a rethinking of clinical trial designAmri HHaramati AAbu-Asab M
collection DOAJ
language English
format Article
sources DOAJ
author Amri H
Haramati A
Abu-Asab M
spellingShingle Amri H
Haramati A
Abu-Asab M
P02.59. Complexity of disease and population heterogeneity require a rethinking of clinical trial design
BMC Complementary and Alternative Medicine
author_facet Amri H
Haramati A
Abu-Asab M
author_sort Amri H
title P02.59. Complexity of disease and population heterogeneity require a rethinking of clinical trial design
title_short P02.59. Complexity of disease and population heterogeneity require a rethinking of clinical trial design
title_full P02.59. Complexity of disease and population heterogeneity require a rethinking of clinical trial design
title_fullStr P02.59. Complexity of disease and population heterogeneity require a rethinking of clinical trial design
title_full_unstemmed P02.59. Complexity of disease and population heterogeneity require a rethinking of clinical trial design
title_sort p02.59. complexity of disease and population heterogeneity require a rethinking of clinical trial design
publisher BMC
series BMC Complementary and Alternative Medicine
issn 1472-6882
publishDate 2012-06-01
work_keys_str_mv AT amrih p0259complexityofdiseaseandpopulationheterogeneityrequirearethinkingofclinicaltrialdesign
AT haramatia p0259complexityofdiseaseandpopulationheterogeneityrequirearethinkingofclinicaltrialdesign
AT abuasabm p0259complexityofdiseaseandpopulationheterogeneityrequirearethinkingofclinicaltrialdesign
_version_ 1724788545573355520